Hikma

Hikma Pharmaceuticals is a global pharmaceutical company dedicated to transforming lives by making high-quality, affordable medicines accessible to people around the world. Founded in 1978, Hikma has built a strong reputation for excellence in generic and branded pharmaceuticals, with a focus on therapeutic areas such as oncology, cardiovascular, central nervous system (CNS), anti-infectives, and respiratory care.

With a presence in over 50 countries, Hikma is a trusted name in the healthcare industry, delivering value through innovation, compliance, and reliable manufacturing. The company operates cutting-edge facilities in the United States, Europe, and the MENA region, all compliant with international Good Manufacturing Practice (GMP) standards. Hikma’s robust pipeline of generic and specialty medicines reflects its ongoing commitment to research, development, and improving patient outcomes.

Hikma’s diverse product portfolio includes oral solids, injectables, and inhalation products, meeting the needs of hospitals, healthcare providers, and patients across multiple markets. Through strategic partnerships and sustained investment in R&D, Hikma continues to strengthen its role as a global leader in the pharmaceutical industry.

Driven by its mission to “put better health within reach every day,” Hikma is more than a pharmaceutical manufacturer—it is a partner in global health. Whether producing life-saving injectables or complex generics, Hikma combines precision, quality, and care to ensure every medicine makes a difference.